(Q44402308)

English

Lamotrigine Versus Valproate Monotherapy—Associated Weight Change in Adolescents With Epilepsy: Results From a Post Hoc Analysis of a Randomized, Double-Blind Clinical Trial

scientific article published on February 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Lamotrigine Versus Valproate Monotherapy—Associated Weight Change in Adolescents With Epilepsy: Results From a Post Hoc Analysis of a Randomized, Double-Blind Clinical Trial (English)

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Victor Biton

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Paul Levisohn

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sheri Hoyler

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Alain Vuong

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Anne E. Hammer

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693782

23 December 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12693782

23 December 2023

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

full work available at URL

http://journals.sagepub.com/doi/pdf/10.1177/08830738030180021701

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Journal of Child Neurology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

133-139

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Childhood and adolescent obesity. Prevalence and significance

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Glucose, insulin concentrations and obesity in childhood and adolescence as predictors of NIDDM.

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Risks and consequences of childhood and adolescent obesity

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Medical hazards of obesity

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Risk of excessive weight gain in epileptic children treated with valproate

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Changes in body weight with chronic, high-dose gabapentin therapy

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril).

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Bodyweight gain and anticonvulsants: a comparative review

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Stable weight during lamotrigine therapy: a review of 32 studies

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Normal growth during lamotrigine monotherapy in pediatric epilepsy patients -- a prospective evaluation of 103 children and adolescents

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Managing pediatric epilepsy syndromes with new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Data collection with adolescents

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Developmental issues influencing guidelines for adolescent health research: a review

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Obesity and endocrine disorders in women taking valproate for epilepsy.

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Adverse effects of valproate.

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Bodyweight change as an adverse effect of drug treatment. Mechanisms and management

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Metabolic changes during treatment with valproate in humans: implication for untoward weight gain

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Body mass index as a measure of adiposity among children and adolescents: A validation study

1 reference

https://api.crossref.org/works/10.1177%2F08830738030180021701

21 January 2018

Prevalence of marked overweight and obesity in a multiethnic pediatric population: findings from the Child and Adolescent Trial for Cardiovascular Health (CATCH) study

3

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Weight loss in patients taking felbamate.

7

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Topiramate--safety and tolerability

8

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures

9

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Multiple sclerosis, HLA, and lymphocyte surface markers

16

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Effects of sodium valproate in 100 children with special reference to weight

17

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Weight gain in epileptic patients during treatment with valproic acid: a retrospective study.

18

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Lamotrigine Monotherapy Improves Depressive Symptoms in Epilepsy: A Double-Blind Comparison with Valproate

27

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Treatment of childhood epilepsy with valproic acid: results of the first 100 patients in a 6-month trial

29

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Valproate and palmitate binding to serum albumin in valproate-treated patients. Relation to obesity

33

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth

38

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy

39

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. The Expert Committee on Clinical Guidelines for Overweight in Adolescent Preventive Services

42

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin

43

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

44

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

An active-control trial of lamotrigine monotherapy for partial seizures

45

1 reference

10.1177/08830738030180021701

https://api.crossref.org/works/10.1177/08830738030180021701

23 December 2023

Identifiers

10.1177/08830738030180021701

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44402308&oldid=2037088694"